Biggest News Aggregation in the World
📰 Felix Study News

Felix Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Felix Study. Real-time updates on events, politics, business and more.

Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study

Claire Roddie, MD, PhD, presents data from the pooled analysis of the ongoing FELIX phase Ib/II study investigating obecabtagene autoleucel in patients with relapsed/refractory adult B-cell acute lymphoblastic leukemia.
San Diego United States Obecabtagene Autoleucel Claire Roddie Pooled Analysis Clin Oncol

Obe-Cel Elicits High Remission Rates in R/R B-ALL Irrespective of Leukemic Burden

Obecabtagene autoleucel elicited durable responses in patients with relapsed or refractory B-cell acute lymphoblastic leukemia independent of leukemic burden at lymphodepletion, although better outcomes were observed in those with lower burden.
United States United Kingdom Claire Roddie American Society Of Clinical Oncology Annual Meeting University College London Clinical Oncology Annual Meeting

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science